Compounds > 5,8,11,14-eicosatetraynoic acid
Page last updated: 2024-10-21

5,8,11,14-eicosatetraynoic acid and Lung Diseases

5,8,11,14-eicosatetraynoic acid has been researched along with Lung Diseases in 1 studies

5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).

Lung Diseases: Pathological processes involving any part of the LUNG.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farrukh, IS1
Michael, JR1
Peters, SP1
Sciuto, AM1
Adkinson, NF1
Freeland, HS1
Paky, A1
Spannhake, EW1
Summer, WR1
Gurtner, GH1

Other Studies

1 other study available for 5,8,11,14-eicosatetraynoic acid and Lung Diseases

ArticleYear
The role of cyclooxygenase and lipoxygenase mediators in oxidant-induced lung injury.
    The American review of respiratory disease, 1988, Volume: 137, Issue:6

    Topics: 5,8,11,14-Eicosatetraynoic Acid; 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Chromones; F

1988